Reviewing cancer biopsy slides with AI and preparing pathology reports
Pathology labs must review biopsy slides and turn findings into reports. Workload peaks and missing subspecialist expertise can leave teams unable to take on cases. Manual data entry adds administrative work, while difficult cases may require a second opinion.
Aiscopia combines digital slide viewing, AI-assisted analysis and report writing for pathology labs. Teams can examine cancer biopsy scans, convert findings into structured reports and request consultations from specialist pathologists.
What stands out about Aiscopia
Co-founder Seyther Morales Burbano practices breast pathology at Centro de Patología de la Mama - Fundación Tejerina.
Selected for Lanzadera's March 2026 accelerator cohort, which supports startups through a tailored growth programme.
Lanzadera reports that Aiscopia completed a functional MVP in 2026 for its AI-assisted cancer-biopsy pathology platform.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.